Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New web tool helps rural doctors spot high blood pressure in kids

NCT ID NCT05126082

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a web-based tool called PedsBP CDS that helps doctors identify and manage high blood pressure in children aged 6-17. The tool was used in 45 primary care clinics across three rural states, involving over 41,000 youth. The goal was to see if the tool improves blood pressure rechecking and diagnosis rates compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PedsBP CDS (a web-based clinical decision support tool)
What this could lead to
If successful, this approach could help more children with high blood pressure get properly diagnosed and managed, especially in rural areas with limited specialist access.
What could go wrong
This is a completed implementation study, not a treatment trial. The tool's effectiveness may vary across different health systems, and it does not directly lower blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

41,054 people

The number who actually took part.

Started

Aug 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 17 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients will be eligible for the PedsBP CDS if 1. 6-17 years of age 2. BP measured and entered in the vital sign section during an ambulatory primary care visit in a randomized primary care clinic 3. not pregnant or postpartum Patients must meet these eligibility criteria to be included into study analyses: 1. have at least one index visit with a primary care provider at a randomized clinic in the intervention period 2. meet eligibility for PedsBP CDS at index visit (a-c above) 3. no previous HT diagnosis prior to index visit 4. not taking antihypertensive medication prior to index visit 5. not opted out of use of their data for research via general consent prior to performing analyses Primary care providers must meet these eligibility criteria to participate in this study: 1. practice at a randomized primary care clinic 2. be a pediatric or family medicine care provider (pediatrician, family physician, nurse practitioner or physician assistant), and 3. provide ongoing clinical care for children and adolescents Exclusion Criteria: Patients will be excluded from analyses if the following criteria are met: 1. outside of the inclusion age range (\<6 years and ≥18 years) at index visit 2. pregnant or postpartum adolescents during study period 3. known HT diagnosis or taking antihypertensive medication at index visit 4. opted out of use of their data for research via general consent prior to performing analyses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Essentia Health

    Duluth, Minnesota, 55805, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.